Runnymede Capital Advisors, Inc. Edwards Lifesciences Corp Transaction History
Runnymede Capital Advisors, Inc.
- $114 Billion
- Q4 2024
A detailed history of Runnymede Capital Advisors, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Runnymede Capital Advisors, Inc. holds 50 shares of EW stock, worth $3,545. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50Holding current value
$3,545% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EW
# of Institutions
1,364Shares Held
475MCall Options Held
9.74MPut Options Held
3.85M-
Vanguard Group Inc Valley Forge, PA69.1MShares$4.9 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.61 Billion0.11% of portfolio
-
Wellington Management Group LLP Boston, MA31.5MShares$2.24 Billion0.37% of portfolio
-
State Street Corp Boston, MA26.3MShares$1.86 Billion0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA13.5MShares$959 Million0.07% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $43.8B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...